Business Description
Xtacy Therapeutics Corp
NAICS : 525990
SIC : 7129
ISIN : CA6993552026
Compare
Compare
Traded in other countries / regions
XTCY.CanadaXTCYF.USATT5.Germany Description
Xtacy Therapeutics Corp is a debt financing company. The company provides a debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It focuses on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | -0.96 | |||||
| Debt-to-Equity | -0.05 | |||||
| Debt-to-EBITDA | -0.03 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -170.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -47.7 | |||||
| 3-Year EBITDA Growth Rate | 21.3 | |||||
| 3-Year EPS without NRI Growth Rate | 21.3 | |||||
| 3-Year FCF Growth Rate | 20.6 | |||||
| 3-Year Book Growth Rate | 27 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.17 | |||||
| 9-Day RSI | 55.05 | |||||
| 14-Day RSI | 49.12 | |||||
| 6-1 Month Momentum % | -68.63 | |||||
| 12-1 Month Momentum % | -23.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.13 | |||||
| Quick Ratio | 0.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -49.4 | |||||
| Shareholder Yield % | -0.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.83 | |||||
| Operating Margin % | -970.69 | |||||
| Net Margin % | -337.93 | |||||
| FCF Margin % | -133.33 | |||||
| ROA % | -62.18 | |||||
| ROIC % | -212.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 25 | |||||
| EV-to-EBIT | -2.63 | |||||
| EV-to-EBITDA | -2.63 | |||||
| EV-to-Revenue | 25.5 | |||||
| EV-to-FCF | -19.46 | |||||
| Earnings Yield (Greenblatt) % | -38.02 | |||||
| FCF Yield % | -5.24 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xtacy Therapeutics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.039 | ||
| EPS (TTM) (€) | -0.002 | ||
| Beta | 1.11 | ||
| Volatility % | 187.75 | ||
| 14-Day RSI | 49.12 | ||
| 14-Day ATR (€) | 0.001387 | ||
| 20-Day SMA (€) | 0.00665 | ||
| 12-1 Month Momentum % | -23.81 | ||
| 52-Week Range (€) | 0.0025 - 0.0555 | ||
| Shares Outstanding (Mil) | 58.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Xtacy Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Xtacy Therapeutics Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Xtacy Therapeutics Corp Frequently Asked Questions
What is Xtacy Therapeutics Corp(STU:TT5)'s stock price today?
The current price of STU:TT5 is €0.01. The 52 week high of STU:TT5 is €0.06 and 52 week low is €0.00.
When is next earnings date of Xtacy Therapeutics Corp(STU:TT5)?
The next earnings date of Xtacy Therapeutics Corp(STU:TT5) is .
Does Xtacy Therapeutics Corp(STU:TT5) pay dividends? If so, how much?
Xtacy Therapeutics Corp(STU:TT5) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers